DAWN BYERS: Open Payments
NPI 1467924241 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,356 in 90 payments from 35 companies in 2025. Trend: 2023 $0 · 2024 $1,416 · 2025 $2,356
Food & beverage: $2,083Education: $273
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $345 |
| AstraZeneca Pharmaceuticals LP | 7 | $205 |
| PFIZER INC. | 8 | $194 |
| ABBVIE INC. | 8 | $159 |
| Genentech USA, Inc. | 5 | $121 |
| GENZYME CORPORATION | 4 | $116 |
| SEAGEN INC. | 1 | $95 |
| Gilead Sciences, Inc. | 4 | $86 |
| Daiichi Sankyo Inc. | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
Products named: ERLEADA, DARZALEX, IBRANCE, Enhertu, SARCLISA, EPKINLY, Trodelvy, KIMMTRAK.
Industry payments across GA — which companies pay providers there.
